Skip to content

A clinical study for the effect of remote monitoring exercise rehabilitation on the discharged patients with novel coronavirus pneumonia (COVID-19)

A clinical study for the effect of remote monitoring exercise rehabilitation on the discharged patients with novel coronavirus pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031834
Enrollment
Unknown
Registered
2020-04-11
Start date
2020-04-20
Completion date
Unknown
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Experimental group:exercise rehabilitation under remote monitoring

Sponsors

Jiangsu Province Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Discharged patients with COVID-19 pneumonia; 2. With dyspnea symptom (mMRC 2~3); 3. Aged 18~75 years old; 4. Have and can use smart phone (study subjects or family members); 5. Obtain the consent of the subjects or legal representative and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Dyspnea scale mMRC 0~1 or 4; 2. Resting heart rate>100bpm; 3. Adjusting dosage of drugs which affect cardiopulmonary function or heart rate (such as: trimetazidine, salbutamol, beta-blocker); 4. Combined uncontrolled chronic disease, such as uncontrolled hypertension (resting BP=160100mmHg), uncontrolled diabetes (random blood glucose>16.7 mmol/l, HbA1C>7.0%); 5. Combined severe organic disease, such as unstable hemodynamic heart disease, heart failure with limited movement (previous diagnosis, or have clinical symptoms of heart failure, after consultation by cardiologist); 6. Cerebrovascular disease occurred within the past 6 months; 7. Active stage of digestive ulcer, thyroid dysfunction, or active tuberculosis; 8. Chronic kidney disease >=stage 3 (eGFR<60ml/min); 9. Have received intra-articular drug injection or surgical treatment in the lower extremity within the past 6 months; 10. Poor compliance, unable to cooperate with assessment or training; 11. Unable to walk independently with auxiliary; 12. Combined mental disease that prevents patients from living independently or receiving treatment; 13. Alcohol abuse or illegal drug use history; 14. Pregnancy, nursing or preparing for pregnancy (including male subjects); 15. Have participated in other clinical trials within the past 3 months.

Design outcomes

Primary

MeasureTime frame
Total distances of 6 minutes walk test;

Secondary

MeasureTime frame
pulmonary function;mMRC dyspnea scale;strength of lower limber muscles;ICF-COVID simple evaluation form;Quality of life;

Countries

China

Contacts

Public ContactLi Jianan

Jiangsu Provincial Hospital

lijianan@njmu.edu.cn+86 13705161766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026